Cited by 171Endometriosis Research and TreatmentOvarian function and disordersGynecological conditions and treatments

In women with endometriosis anti-mullerian hormone levels are decreased only in those with previous endometrioma surgery

Streuli, I., de Ziegler, D., Gayet, V., Santulli, P., Bijaoui, G., de Mouzon, J., Chapron, C.·2012·Human Reproduction

Abstract

STUDY QUESTION: Are anti-Müllerian hormone (AMH) levels lower in women with endometriosis, notably those with endometriomas (OMAs) and deep infiltrating lesions, compared with controls without endometriosis? SUMMARY ANSWER: Endometriosis and OMAs per se do not result in lower AMH levels. AMH levels are decreased in women with previous OMA surgery independently of the presence of current OMAs. WHAT IS KNOWN ALREADY: The impact of endometriosis and OMAs per se on the ovarian reserve is controversial. Most previous studies have been conducted in infertile women. The strength of our study lies in the following points: (i) the selection of women undergoing surgery and not only according to the presence of infertility, (ii) the classification of women with endometriosis and controls based on strict surgical and histological criteria. STUDY DESIGN, SIZE, DURATION: Cross-sectional study using data prospectively collected in all non-pregnant <42-year-old patients, who were surgically explored for a benign gynaecological condition at a university tertiary referral centre between 2004 and 2008. For each patient, a structured questionnaire was completed during a face-to-face interview conducted by the surgeon during the month preceding surgery. AMH levels were measured in serum samples drawn in the month preceding surgery, without regard to menstrual phase or hormonal therapy. PARTICIPANTS/MATERIALS, SETTING, METHODS: Operations were done on 1262 women between 2004 and 2008, of which 1133 signed the informed consent. Of the 566 women with a visual diagnosis of endometriosis, 411 had histologically proven endometriosis. Frozen serum samples for the AMH measurement were available in 313 of them. Out of the 554 women without visual endometriosis and without past endometriosis surgery, 413 had a frozen serum sample for the AMH measurement. Univariate analysis examined AMH levels according to baseline patient characteristics, the presence and type of endometriosis (superficial lesion, OMA, deep infiltrating lesion) and previous OMA surgery. Analysis of variance-covariance then examined the effects of co-variables on AMH levels. Finally, logistic regressions were conducted to examine the odds ratio (OR) of having AMH levels <1 ng/ml according to the same co-variables. MAIN RESULTS AND THE ROLE OF CHANCE: The difference in AMH levels between women with endometriosis and controls did not reach significance (3.6 ± 3.1 versus 4.1 ± 3.4 ng/ml, P = 0.06). Analysis of variance-covariance demonstrated that AMH levels significantly decreased with age (P < 0.001) and in women with prior OMA surgery irrespective of whether OMAs were present or not at the time of study (P < 0.05). Logistic regression revealed that two major factors were related to AMH levels <1 ng/ml: (i) age (compared with <29 years; 30-34 years OR = 3.1, 95% CI: 1.5-6.4, P = 0.01; 35-39 years OR = 7.0, 95% CI: 3.5-14.1, P = 0.001; ≥40 years OR = 20.8, 95% CI: 9.1-47.4, P = 0.001) and (ii) prior OMA surgery (OR = 3.0, 95% CI: 1.4-6.41, P = 0.01). LIMITATIONS, REASONS FOR CAUTION: The selection of our study population was based on a surgical diagnosis. Women with an asymptomatic form of endometriosis are therefore not included in our study. We cannot exclude that infertile women with OMAs associated with a diminished ovarian reserve, as assessed during their infertility work-up, were less likely to be referred for surgery and might therefore be underrepresented. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that OMAs per se do not diminish the ovarian reserve reflected by AMH levels but that alterations seen in women with endometriosis are a deleterious consequence of OMA surgery. These findings should be taken into account in the decision to operate OMAs in women with a desire for future pregnancy. STUDY FUNDING: none. Potential competing interests: none.

Integrity signals

Registry

Crossref · 10.1093/humrep/des274

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mounting evidence suggests that surgery for endometriosis may harm ovarian reserve more than the disease itself.

    “Moreover, mounting evidence arose suggesting that surgery for endometriosis is potentially prone to harm the ovarian reserve, even more than the disease itself (48,49).”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [48]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Streuli, I., de Ziegler, D., Gayet, V., Santulli, P., Bijaoui, G., de Mouzon, J., & Chapron, C.
Affiliations
  • Sorbonne Paris Cité (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Chapron, C.
Venue
Human Reproduction
Published
2012-07-20
Volume
27
Issue
11
Pages
3294-3303
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2134123087
Cited by
171
References
52
Citations by year
2026: 7 · 2025: 14 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 14 · 2017: 13 · 2016: 12 · 2015: 20 · 2014: 14 · 2013: 9 · 2012: 1
FWCI
16.44
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, anti-Müllerian hormone, ovarian reserve, endometrioma, deep infiltrating endometriosis, ovarian reserve markers, women of reproductive age
MeSH terms
Adult, Age Factors, Cross-Sectional Studies, Endometriosis, Female, Hospitals, University, Humans, Infertility, Female, Paris, Prospective Studies, Surveys and Questionnaires, Recurrence, Reoperation, Severity of Illness Index, Statistics as Topic, Down-Regulation, Anti-Mullerian Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review